483
Baxter CorporationBaxter Corporation – FDA 483, Jan 31, 2025
Record Details
Baxter Corporation, a parenteral drug manufacturer in Alliston, was cited for significant deficiencies during an FDA inspection. Observations included inadequate investigations into unexplained discrepancies and packaging failures, issues with manufacturing process validation and container integrity, and failures in preventing contamination and conducting proper component identification testing. These issues indicate a lack of robust quality control and investigation practices.
View Company Profile
ID · 8961015e-1405-44a8-86c9-d493cffcdf40
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.